Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability

Abstract

Although in our animal model PPIs induced intestinal overgrowth, stage of liver disease rather than PPI use was the predominant factor determining infection risk in cirrhotic patients. Increased intestinal permeability may be a factor contributing to infection risk.